Findings from the phase 3 SIERRA study showed that Iomab-B was associated with a higher durable complete response rate vs ...

A new study aims to investigate the feasibility and impact of multidisciplinary prehabilitation in adults with acute myeloid ...

The researchers suggest certain refinements to the 2022 European LeukemiaNet classification model for patients aged 60 years ...

Vor Biopharma Inc. (NASDAQ:VOR) announced new clinical data from its ongoing Phase 1/2 VBP101 study of patients with relapsed ...

A Flint woman may be the first in the world with leukemia to undergo a transplant using stem cells from the bone marrow of a ...

For most people, the word cancer implies that there’s a tumor or mass growing somewhere in the body. However, contrary to ...

和急性髓系白血病（AML）患者的首次报告：来自I期研究的数据汇报讲者：齐军元 中国医学科学院血液病医院 Efficacy and Safety of a Phase 2 Study：Timdarpacept （IMM01） Combined with Azacitidine（AZA）As the First-Line Treatment in Adults with Chronic ...

The NHS England has announced the routine commissioning of Daiichi Sankyo's quizartinib for acute myeloid leukaemia (AML).

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...

Syndax's pending PDUFA has blockbuster potential, but FDA approval remains uncertain, posing significant risk. Read why SNDX ...

Ariane Navarro, a cancer survivor, now works with her doctor to promote umbilical cord blood donation.